Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Hans U. Schmelz"'
Autor:
Hadi Mostafaei, Kristin Zimmermann, Hans U. Schmelz, Keiichiro Mori, Shahrokh F. Shariat, Axel Heidenreich
Publikováno v:
Current Opinion in Urology. 31:304-314
Purpose of review Several instruments have been designed to evaluate health-related quality of life (HRQoL) in patients with bladder cancer (BC). However, they vary in purpose, domains, and quality. To identify QoL instruments that have been validate
Autor:
Hadi Mostafaei, Hans U. Schmelz, Axel Heidenreich, Keiichiro Mori, Shahrokh F. Shariat, Kristin Zimmermann
Publikováno v:
Current Opinion in Urology. 31:297-303
Purpose of review Although survival outcomes are the primary outcomes to determine the effectiveness of treatment options, quality of life (QoL) is gaining in importance in addition to classic oncological outcomes. The present review aims to state an
Autor:
Christian Ruckes, Andreas Hiester, Christian Bolenz, Christian Ruf, D Nettersheim, Maximilian Peter Brandt, Tim Nestler, Axel Haferkamp, Peter Albers, Axel Heidenreich, Klaus-Peter Dieckmann, Isabella Syring, Robert Dotzauer, Friedemann Zengerling, Pia Paffenholz, David Pfister, Hans U. Schmelz, Sven H. Loosen
Purpose Clinical stage I (CSI) testicular germ cell tumors (TGCT) represents disease confined to the testis without metastasis and CSIS is defined as persistently elevated tumor markers (TM) after orchiectomy, indicating subclinical metastatic diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ab2fc693f34d434762f7a4f6ab6f3ca
Publikováno v:
Die Urologie ISBN: 9783642411687
Die Urologie ISBN: 9783642399398
Die Urologie ISBN: 9783642399398
Sowohl Seminome als auch nichtseminomatose Keimzelltumoren konnen auch im weit fortgeschrittenen Tumorstadium durch Einleitung einer standardisierten Chemotherapie in einem grosen Prozentsatz geheilt werden. Das Seminom als strahlensensibler Tumor ka
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dffec998f7935cfeb95313c1a67ce83
https://doi.org/10.1007/978-3-642-41168-7_178-2
https://doi.org/10.1007/978-3-642-41168-7_178-2
Autor:
Oliver W. Hakenberg, Christian Ruf, Jonas Busch, Johannes Classen, Hans U. Schmelz, Friedemann Zengerling, Julia Lackner, Alexandros Papachristofilou, Carsten Bokemeyer, Heinz Schmidberger, Stefanie Schmidt, Annette Dieing, Christoph Oing, Susanne Krege, Julia Heinzelbecker, Peter Albers, Christian Winter, Sabine Kliesch, Rainer Souchon, David Pfister
Publikováno v:
World journal of urology. 40(12)
Purpose The optimal treatment for clinical stage (CS) IIA/IIB seminomas is still controversial. We evaluated current treatment options. Methods A systematic review was performed. Only randomized clinical trials and comparative studies published from
Autor:
Kristin, Zimmermann, Hadi, Mostafaei, Axel, Heidenreich, Hans U, Schmelz, Shahrokh F, Shariat, Keiichiro, Mori
Publikováno v:
Current opinion in urology. 31(4)
Several instruments have been designed to evaluate health-related quality of life (HRQoL) in patients with bladder cancer (BC). However, they vary in purpose, domains, and quality. To identify QoL instruments that have been validated for BC patients
Autor:
Kristin, Zimmermann, Hadi, Mostafaei, Axel, Heidenreich, Hans U, Schmelz, Shahrokh F, Shariat, Keiichiro, Mori
Publikováno v:
Current opinion in urology. 31(4)
Although survival outcomes are the primary outcomes to determine the effectiveness of treatment options, quality of life (QoL) is gaining in importance in addition to classic oncological outcomes. The present review aims to state and critically asses
Autor:
Peter Albers, Michael Hartmann, Jan Lehmann, Andreas Hiester, Volker Loy, Anna Fingerhut, Sabine Kliesch, Maik Pechoel, Klaus-Peter Dieckmann, Rolf Fimmers, Peter Kwasny, Susanne Krege, Kai Uwe Koehrmann, Hans U. Schmelz, Christian Wittekind, Roswitha Siener, Axel Heidenreich, Guenter Niegisch
Publikováno v:
Journal of Clinical Oncology. 38:5512-5512
5512 Background: One cycle of adjuvant BEP has shown superiority in recurrence free survival over RPLND in patients (pts) with clinical stage (CS) I nonseminomatous germ cell tumor of the testis (NSGCT) (JCO 2008). We report recurrences and late toxi
Autor:
Hans U. Schmelz, Tim Nestler
Publikováno v:
Urologic Oncology ISBN: 9783319426037
Urologic Oncology
Urologic Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f61ea2260fdbfbc6a77c4bb383db339b
https://doi.org/10.1007/978-3-319-42603-7_1-1
https://doi.org/10.1007/978-3-319-42603-7_1-1
Autor:
Christian Ruf, Christopher Netsch, Andreas Neisius, Kai Nestler, Stephan Waldeck, Tim Nestler, Hans U. Schmelz, Hendrik Isbarn
Publikováno v:
World journal of urology. 37(4)
Uric acid (UA) calculi can be referred to chemolitholysis rather than invasive treatment. Dual-energy computed tomography (DECT) may be able to distinguish between UA and non-UA (NUA) calculi. The aim of this study was to evaluate the validity of thi